Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
HIV Research & Clinical Practice
Volume 24, 2023 - Issue 1
Research Article
Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study
Hernando Knobel1 Department of Infectious Diseases, Hospital del Mar, Barcelona, Spain;2 Department of Medicine and Life Sciences (MELIS), Univ. Pompeu Fabra, Barcelona, Spain;3 Centro de Investigación Biomédica en Red en Infecciones (CIBERINFECC), Madrid, SpainCorrespondence[email protected]
https://orcid.org/0000-0003-3186-6416View further author information
https://orcid.org/0000-0003-3186-6416View further author information, Esperanza Cañas-Ruano1 Department of Infectious Diseases, Hospital del Mar, Barcelona, Spainhttps://orcid.org/0000-0002-4651-7545View further author information
https://orcid.org/0000-0002-4651-7545View further author information, Ana Guelar1 Department of Infectious Diseases, Hospital del Mar, Barcelona, Spainhttps://orcid.org/0000-0001-6697-2652View further author information
https://orcid.org/0000-0001-6697-2652View further author information, Pablo Knobel4 Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USAhttps://orcid.org/0000-0001-6902-0286View further author information
https://orcid.org/0000-0001-6902-0286View further author information, Judit Villar-García1 Department of Infectious Diseases, Hospital del Mar, Barcelona, Spain;2 Department of Medicine and Life Sciences (MELIS), Univ. Pompeu Fabra, Barcelona, Spainhttps://orcid.org/0000-0002-6767-3424View further author information
https://orcid.org/0000-0002-6767-3424View further author information, , Ceclia Canepa1 Department of Infectious Diseases, Hospital del Mar, Barcelona, Spainhttps://orcid.org/0009-0001-0908-0719View further author information
https://orcid.org/0009-0001-0908-0719View further author information, Itziar Arrieta-Aldea1 Department of Infectious Diseases, Hospital del Mar, Barcelona, Spainhttps://orcid.org/0000-0002-4655-4151View further author information
https://orcid.org/0000-0002-4655-4151View further author information, Augustin Marcos1 Department of Infectious Diseases, Hospital del Mar, Barcelona, Spainhttps://orcid.org/0000-0002-5784-2546View further author information
https://orcid.org/0000-0002-5784-2546View further author information, & Roberto Güerri-Fernández1 Department of Infectious Diseases, Hospital del Mar, Barcelona, Spain;2 Department of Medicine and Life Sciences (MELIS), Univ. Pompeu Fabra, Barcelona, Spain;3 Centro de Investigación Biomédica en Red en Infecciones (CIBERINFECC), Madrid, Spainhttps://orcid.org/0000-0002-9794-9161View further author information
https://orcid.org/0000-0002-9794-9161View further author information show all